| Autor: |
Harrina Erlianti, Rahardjo, Fina, Widia, Mega Anara, Manurung, Indra, Wicaksono, Soefiannagoya, Soedarman, Haryo Prakoso Adhi, Purwanto, Ahmad Aulia, Rizaly, Kevin, Leonardo, Andika, Afriansyah |
| Rok vydání: |
2022 |
| Zdroj: |
Urology journal. |
| ISSN: |
1735-546X |
| Popis: |
The current study aims to compare the effectiveness of pre-urodynamic single-dose levofloxacin and post-urodynamic levofloxacin for three days related to the incidence of urinary tract infections post-urodynamic examination.This is a single-blind randomized clinical trial conducted in three outpatient urology centers in Jakarta: Cipto Mangunkusumo General Hospital, Siloam Asri Hospital, and Persahabatan General Hospital using a consecutive sampling method between July 2019 - February 2022. The outcome of the study is the incidence of urinary tract infections in both treatment groups. Urinary tract infection was defined as a patient with one or more clinical symptoms of lower urinary tract infection and one or more urinalysis parameters positive for urinary tract infections. Chi-square was used to evaluate the association where p0.05 was used to determine statistical significance.A total of 126 patients (63 patients in each arm) were included in the evaluation and analysis. Overall, urinary tract infections were detected in 25 cases (19.8%), 12 patients from the pre-urodynamic antibiotic group (9.5%) and 13 patients from the post-urodynamic antibiotic group (10.3%) (P = .823). E.coli was the most common bacteria found in the urine culture.There is no significant difference between a single dose of 500 mg of Levofloxacin administered one hour before the urodynamic study and a once-daily dose of 500 mg of Levofloxacin for three days following the urodynamic study related to urinary tract infections prevention post-urodynamic examination. |
| Databáze: |
OpenAIRE |
| Externí odkaz: |
|
